Osaka, Japan

Takashi Ichikawa


 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Suita, JP (2006 - 2008)
  • Osaka, JP (2011 - 2012)

Company Filing History:


Years Active: 2006-2012

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Unveiling the Innovative Work of Takashi Ichikawa in Osaka, JP

Introduction:

Takashi Ichikawa, a talented inventor based in Osaka, JP, has made significant contributions to the field of pharmaceuticals with his groundbreaking research and patented inventions.

Latest Patents:

Takashi Ichikawa's latest patents focus on Polo-like kinase inhibitors, comprising compounds designed for use with kinases. These compounds, along with pharmaceutical compositions, kits, and articles of manufacture, offer promising prospects for the treatment of various diseases. The methods and intermediates provided for making the compounds demonstrate his expertise in pharmaceutical innovation.

Career Highlights:

Currently employed at Takeda Pharmaceutical Company Limited, Takashi Ichikawa showcases his dedication to advancing the pharmaceutical industry through his inventive work. With a total of 4 patents to his name, he has established himself as a leading figure in the field of drug development and research.

Collaborations:

Collaborating with esteemed colleagues such as Stephen W Kaldor and Norikazu Tamura, Takashi Ichikawa leverages collective expertise to push the boundaries of pharmaceutical innovation. Their combined efforts have led to significant advancements in the development of novel compounds and treatment strategies.

Conclusion:

In conclusion, Takashi Ichikawa's inventive spirit and commitment to excellence shine through in his impressive portfolio of patents. His contributions to the field of pharmaceuticals, particularly in the realm of Polo-like kinase inhibitors, underscore his status as a pioneering inventor shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…